Bloomberg -- GlaxoSmithKline Plc (GSK) is grappling with a “war for talent” in China and India as the U.K. drugmaker struggles to retain sales representatives needed to expand in the world’s fastest-growing markets.
Bloomberg -- GlaxoSmithKline Plc (GSK) is grappling with a “war for talent” in China and India as the U.K. drugmaker struggles to retain sales representatives needed to expand in the world’s fastest-growing markets.
